Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METHOTREXATE Cause Product communication issue? 39 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Product communication issue have been filed in association with METHOTREXATE (Methotrexate). This represents 0.0% of all adverse event reports for METHOTREXATE.

39
Reports of Product communication issue with METHOTREXATE
0.0%
of all METHOTREXATE reports
9
Deaths
24
Hospitalizations

How Dangerous Is Product communication issue From METHOTREXATE?

Of the 39 reports, 9 (23.1%) resulted in death, 24 (61.5%) required hospitalization, and 7 (17.9%) were considered life-threatening.

Is Product communication issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METHOTREXATE. However, 39 reports have been filed with the FAERS database.

What Other Side Effects Does METHOTREXATE Cause?

Drug ineffective (70,142) Rheumatoid arthritis (29,254) Off label use (24,020) Pain (23,773) Drug intolerance (22,555) Arthralgia (21,831) Fatigue (19,885) Nausea (18,715) Joint swelling (17,657) Drug hypersensitivity (16,677)

What Other Drugs Cause Product communication issue?

EVOLOCUMAB (2,341) SEMAGLUTIDE (842) ERENUMAB-AOOE (598) SOMATROPIN (350) PEGFILGRASTIM (333) ETANERCEPT (122) ALBUTEROL (121) NIRMATRELVIR\RITONAVIR (70) DENOSUMAB (68) LEVODOPA (61)

Which METHOTREXATE Alternatives Have Lower Product communication issue Risk?

METHOTREXATE vs METHOXSALEN METHOTREXATE vs METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA METHOTREXATE vs METHYL ALCOHOL METHOTREXATE vs METHYLCOBALAMIN METHOTREXATE vs METHYLDOPA

Related Pages

METHOTREXATE Full Profile All Product communication issue Reports All Drugs Causing Product communication issue METHOTREXATE Demographics